EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Translational Regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript Modifications

Sumeen Kaur Gill iD, Richard H Gomer iD

Cells · 03.04.2025 · 14 (7) · 536

DOI: 10.3390/cells14070536 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 03.04.2025. Verfasst von Sumeen Kaur Gill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Idiopathic Pulmonary Fibrosis, Protein Biosynthesis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas A&M University, Texas A&M University start-up funds for Richard Gomer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosing disorders including idiopathic pulmonary fibrosis (IPF) are progressive irreversible diseases, often with poor prognoses, characterized by the accumulation of excessive scar tissue and extracellular matrix. Translational regulation has emerged as a critical aspect of gene expression control, and the dysregulation of key effectors is associated with disease pathogenesis. This review examines the current literature on translational regulators in IPF, focusing on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA transcript modifications including alternative polyadenylation and chemical modification. Some of these translational regulators potentiate fibrosis, and some of the regulators inhibit fibrosis. In IPF, some of the profibrotic regulators are upregulated, and some of the antifibrotic regulators are downregulated. Correcting these defects in IPF-associated translational regulators could be an intriguing avenue for therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRNA, Long NoncodingIdiopathic Pulmonary FibrosisProtein BiosynthesisHumansAnimalsGene Expression Regulation

Stichwörter der Autor:innen

alternative polyadenylationepigenetic modificationsidiopathic pulmonary fibrosislong non-coding RNAmicroRNAtranslation

Substanzen

MicroRNAsRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Biology, Texas A&M University, College Station, TX 77843, USA.

ORCID-Profile: Sumeen Kaur Gill, Richard H Gomer

Förderung

  • Texas A&M University
  • Texas A&M University start-up funds for Richard Gomer

Zitieren

APA

Gill, S. K., & Gomer, R. H. (2025). Translational Regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript Modifications. Cells, 14(7), 536. https://doi.org/10.3390/cells14070536

Vancouver

Gill SK, Gomer RH. Translational Regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript Modifications. Cells. 2025;14(7):536. doi:10.3390/cells14070536

BibTeX
@article{Gill2025,
  author = {Gill, Sumeen Kaur and Gomer, Richard H},
  title = {Translational Regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript Modifications},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {536},
  doi = {10.3390/cells14070536}
}
Kostenlos starten →